食品饮料 2025 年 12 月 14 日 投资评级：看好（维持） 行业走势图 数据来源：聚源 -19% -10% 0% 10% 19% 29% 2024-12 2025-04 2025-08 食品饮料 沪深300 相关研究报告 《白酒短期批价扰动，西麦新品值得 关注—行业周报》-2025.12.7 《茅台韧性凸显，建议长期配置布局 —行业周报》-2025.11.30 《乳制品供需拐点可期，三大机会驱 动行业成长—行业周报》-2025.11.23 中央经济工作会议积极定调，飞天批价或止跌触底 ——行业周报 张宇光（分析师） 张思敏（分析师） zhangyuguang@kysec.cn 证书编号：S0790520030003 zhangsimin@kysec.cn 证书编号：S0790525080001 核心观点：政策红利提振消费情绪，贵州茅台加码控价 12 月 8 日-12 月 12 日，食品饮料指数跌幅为 1.6%，一级子行业排名第 21，跑输 沪深 300 约 1.5pct，子行业中其他食品（+0.0%）、乳品（-1.1%）、啤酒（-1.3%） 表现相对领先。本周中央经济工作会议将"坚持内需主导，建设强大 ...

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The pork price is expected to rise due to limited supply before the New Year, with the average price of live pigs at 11.43 yuan/kg as of December 12, 2025, showing a week-on-week increase of 0.22 yuan/kg but a year-on-year decrease of 4.33% [12][13] - The beef market is showing signs of a bullish cycle, with the wholesale price of beef at 66.24 yuan/kg, up 10.22% year-on-year, and calf prices at 32.23 yuan/kg, up 33.68% year-on-year [24] - The pig farming sector is facing accelerated losses, leading to a potential increase in the pace of pig culling, while the pet sector is benefiting from domestic brand growth due to consumption upgrades and tariff barriers [27][31] Summary by Sections Weekly Observation - The cold wave is boosting pork consumption as the pickled meat season approaches, with limited supply expected before the New Year [12] - The average weight of pigs slaughtered is 129.63 kg, with a decrease in the proportion of smallholder sales [12][13] Weekly Market Performance (Dec 8-12) - The agricultural sector outperformed the market by 0.26 percentage points, with the Shanghai Composite Index down 0.34% and the agricultural index down 0.08% [32] - Leading stocks included *ST Zhengbang (+19.40%), Biological Shares (+17.16%), and Luoniushan (+13.73%) [32][39] Price Tracking (Dec 8-12) - The average price of live pigs was 11.48 yuan/kg, up 2.50% week-on-week, while the price of piglets was 19.04 yuan/kg, down 1.14% [41] - The average price of beef was 66.13 yuan/kg, showing a slight decrease [48] Key News (Dec 8-12) - China's soybean imports for the first 11 months of 2025 reached 104 million tons, an increase of 6.9% year-on-year, with a price drop of 10.7% [40]

数据来源：聚源 -19% -10% 0% 10% 19% 29% 38% 2024-12 2025-04 2025-08 汽车 沪深300 汽车研究团队 邓健全（首席分析师） 证书编号：S0790525090003 赵悦媛（联席首席分析师） 证书编号：S0790525100003 赵旭杨（分析师） 证书编号：S0790523090002 傅昌鑫（分析师） 证书编号：S0790525090005 汽车 2025 年 12 月 14 日 投资评级：看好（维持） 行业走势图 相关研究报告 《鸿蒙智行尊界 S800 轿车 11 月交付 破 2000 台，宇树科技完成 IPO 辅导— 行业周报》-2025.12.7 《特斯拉 FSD V14.2.1 上线，长安汽车 拟 2.25 亿元参与设立机器人公司—行 业周报》-2025.11.30 《小鹏汽车第 100 万台整车下线，广 州车展车企竞逐具身智能新赛道—行 业周报》-2025.11.23 "两新"政策有望优化实施，客车行业出口加速 ——行业周报 | 邓健全（分析师） | 赵悦媛（分析师） | 傅昌鑫（分析师） | | --- | --- | --- | | deng ...

计算机 2025 年 12 月 14 日 投资评级：看好（维持） 行业走势图 数据来源：聚源 -24% -12% 0% 12% 24% 36% 2024-12 2025-04 2025-08 计算机 沪深300 相关研究报告 《商业航天，大国重器—行业深度报 告》-2025.12.11 《重视商业航天产业大趋势—行业周 报》-2025.12.7 《商业航天有望进入高速发展期—行 业周报》-2025.11.30 周观点：商业航天产业催化密集 ——行业周报 | 陈宝健（分析师） | 刘逍遥（分析师） | | --- | --- | | chenbaojian@kysec.cn | liuxiaoyao@kysec.cn | | 证书编号：S0790520080001 | 证书编号：S0790520090001 | liuxiaoyao@kysec.cn 证书编号：S0790520090001 市场回顾：本周（2025.12.8-2025.12.12），沪深 300 指数下跌 0.08%，计算 机指数下跌 1.14%。 周观点：AI 产业持续繁荣 （1）SpaceX 或将开启史上最大规模 IPO，目标估值约 1.5 ...

Investment Rating - The investment rating for the pharmaceutical and biotechnology industry is "Positive" (maintained) [1] Core Insights - The 2025 National Medical Insurance Negotiation results were announced, with 114 new drugs added to the medical insurance directory, achieving an overall success rate of 88%, the highest in nearly seven years, with a maximum price reduction of 94 [4][19] - The newly added drugs include monoclonal antibodies, bispecific antibodies, ADCs, siRNA, and small molecules, indicating a strong focus on innovative therapies [19][32] - The commercial insurance directory has added 19 innovative drugs, which, while not reimbursed by medical insurance, receive support for innovative drug applications, enhancing patient access and benefiting the innovative drug industry [5][24] Summary by Sections 1. National Medical Insurance Negotiation Results - The 2025 medical insurance directory added 114 new drugs, with a success rate of 88% and a maximum price reduction of 94% [4][13] - The total number of drugs in the national medical insurance directory reached 3,253, including 1,857 Western medicines and 1,396 traditional Chinese medicines [16][17] - The directory reflects a significant increase in the inclusion of innovative drugs, with 50 of the new additions classified as category 1 innovative drugs [19][21] 2. Commercial Insurance Directory - The commercial insurance directory added 19 innovative drugs, highlighting their clinical value and innovation [24][28] - The directory includes treatments for diseases such as Alzheimer's, rare diseases in children, and other critical conditions, showcasing a focus on addressing unmet medical needs [24][28] - The support for innovative drugs in the commercial insurance directory aims to fill gaps in patient coverage and enhance the overall healthcare system [25][28] 3. Market Performance - In the second week of December, the pharmaceutical and biotechnology sector declined by 1.04%, underperforming the CSI 300 index by 0.96 percentage points [6][34] - The medical research outsourcing sector showed the highest increase, up by 3.69%, while offline pharmacy and medical circulation sectors experienced the largest declines [6][36] 4. Recommended Companies - The report continues to favor innovative drugs and their supply chain, recommending companies such as Sanofi, Innovent Biologics, and others for investment [7][32]

2025 年 12 月 14 日 金融工程研究团队 魏建榕（首席分析师） 证书编号：S0790519120001 苏俊豪（分析师） 证书编号：S0790522020001 胡亮勇（分析师） 证书编号：S0790522030001 王志豪（分析师） 证书编号：S0790522070003 盛少成（分析师） 证书编号：S0790523060003 蒋 韬（分析师） 证书编号：S0790525070001 相关研究报告 《基于港交所 CCASS 数据的港股投 资策略》-20250914 《国庆前后的港股市场资金流变化》 -2024.10.18 《公募港股投资变化及港股通优选组 合构建》-2024.7.15 《港股优选：技术面、资金面、基本 面》-2022.3.22 《对近期北向持续撤离，南下持续抄 底的几点思考》-2022.3.15 傅开波（分析师） 证书编号：S0790520090003 高 鹏（分析师） 证书编号：S0790520090002 基于杠反 ETF 份额变化的港股择时策略 ——开源量化评论（115） 魏建榕（分析师） 傅开波（分析师） weijianrong@kysec.cn 证书编号：S07905 ...

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The non-bank financial index increased by 0.81%, outperforming the CSI 300 index which decreased by 0.08%. The brokerage and insurance sectors continue to show good trends, with valuations at low levels and relatively stagnant performance throughout the year. The Federal Reserve's interest rate cuts are beneficial for the equity market, directly favoring the profitability of securities firms' overseas businesses due to lower liability costs and asset expansion [4][5] - The average daily trading volume of stock funds reached 2.39 trillion, a 15.1% increase month-on-month, indicating a recovery in trading activity. The cumulative average daily trading volume for the year is 2.05 trillion, a 69.5% year-on-year increase [5] - The China Securities Regulatory Commission's recent positive stance signals a potential "policy easing period" for the industry, which may lead to an increase in leverage limits and support for the profitability of the securities industry. The report recommends focusing on strategic opportunities in undervalued leading companies in the brokerage and insurance sectors [5][6] Summary by Sections Brokerage Sector - The Federal Reserve's interest rate cuts are favorable for the overseas business of brokerages, and new regulations are set to standardize fund sales practices. The report highlights three main lines of recommended stocks: Huatai Securities, Guotai Junan, and CICC for their advantages in overseas and institutional business; GF Securities and Dongfang Securities for their wealth management strengths; and Guosen Securities for its retail advantages [5][6][7] Insurance Sector - The liability side is expected to achieve a "good start," with the transformation of dividend insurance continuing to progress. The demand for "savings" from residents is likely to persist, and the insurance distribution channel is expected to maintain high growth. On the asset side, stable long-term interest rates and a favorable equity market are expected to boost investment returns in the medium to long term [6][7]

商贸零售 商贸零售 2025 年 12 月 14 日 投资评级：看好（维持） 行业走势图 数据来源：聚源 -36% -24% -12% 0% 12% 24% 2024-12 2025-04 2025-08 商贸零售 沪深300 相关研究报告 《林清轩更新招股书，关注高端国货 护 肤 公 司 上 市 进 展 — 行 业 周 报 》 -2025.12.7 《医美化妆品 11 月月报：美丽田园收 购思妍丽 100%股权，双十一大促落幕 美 妆 表 现 亮 眼 — 行 业 点 评 报 告 》 -2025.12.3 《从保值到颜值，再到情绪价值—行 业投资策略》-2025.12.3 商务部明确零售品质转型，关注永辉超市调改成效 ——行业周报 黄泽鹏（分析师） 李昕恬（联系人） huangzepeng@kysec.cn 证书编号：S0790519110001 lixintian@kysec.cn 证书编号：S0790125100021 商务部对零售行业定调积极，关注永辉超市调改变革 本周（12 月 9 日至 10 日），全国零售业创新发展大会在北京召开，会议提出学 习推广胖东来好经验好做法加快转型提升。商务部副部长盛秋平 ...

通信 2025 年 12 月 14 日 投资评级：看好（维持） 行业走势图 数据来源：聚源 -24% 0% 24% 48% 72% 96% 2024-12 2025-04 2025-08 通信 沪深300 相关研究报告 《国内 AIDC 需求或加速回暖—行业 点评报告》-2025.12.9 《"H200 芯片或放开"下的投资机会 梳理—行业点评报告》-2025.12.9 《"AI+卫星"的共振—行业周报》- 2025.12.7 GPT5.2 发布， "AI+卫星"为核心主线 ——行业周报 | 蒋颖（分析师） | 陈光毅（联系人） | 雷星宇（联系人） | | --- | --- | --- | | jiangying@kysec.cn | chenguangyi@kysec.cn | leixingyu@kysec.cn | | 证书编号：S0790523120003 | 证书编号：S0790124020006 | 证书编号：S0790124040002 | OpenAI 发布最新模型 GPT-5.2，赶超人类专家 12 月 11 日，GPT5.2 在 ChatGPT 上线并推出 Instant、Thinki ...

综合 2025 年 12 月 14 日 投资评级：看好（维持） 行业走势图 数据来源：聚源 -29% -14% 0% 14% 29% 43% 2024-12 2025-04 2025-08 综合 沪深300 相关研究报告 《谷歌 Gemini3 增益生态，存储有望 持续高景气—行业周报》-2025.12.7 《AI 需求持续验证，提升算力需求可 预见性—行业周报》-2025.11.23 《AI 需求可预见性愈发清晰，关注 Robotaxi 产 业 机 会 — 行业周报》 -2025.11.16 存储依然高景气，H200 有望获批对华出口 ——行业周报 | 初敏（分析师） | 张可（分析师） | 杨哲（分析师） | | --- | --- | --- | | chumin@kysec.cn | zhangke1@kysec.cn | yangzhe@kysec.cn | | 证书编号：S0790522080008 | 证书编号：S0790523070001 | 证书编号：S0790524100001 | 电子：H200 有望获批对华出口，长期看好国产替代 2025 年 12 月 9 日美国总统特朗普宣布在确保美 ...